Chemgenes Corporation
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
8
Ending by 2030
Aug 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 20, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,932,287 | Therapeutic Compositions and Uses In force · High confidence | In force | High confidence | |
| US 8,309,707 | RNA Synthesis-Phosphoramidites for Synthetic RNA in the Reverse Direction, and Application in Convenient Introduction of Ligands, Chromophores and Modifications of Synthetic RNA at the 3'-END In force · Medium confidence | In force | Medium confidence | |
| US 8,933,214 | RNA Synthesis-Phosphoramidites for Synthetic RNA in the Reverse Direction, and Application in Convenient Introduction of Ligands, Chromophores and Modifications of Synthetic RNA at the 3'-END In force · Medium confidence | In force | Medium confidence | |
| US 9,605,261 | RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end In force · USPTO record | In force | USPTO record | |
| US 8,536,318 | Chemical RNA Synthesis Method In force · High confidence | In force | High confidence | |
| US 7,956,169 | Synthesis of novel azo-dyes and their use in oligonucleotide synthesis In force · USPTO record | In force | USPTO record | |
| US 8,530,634 | Method of oligonucleotide labeling using cycloaddition reaction In force · USPTO record | In force | USPTO record | |
| US 8,541,569 | Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA In force · USPTO record | In force | USPTO record | |
| US 8,981,076 | Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis In force · High confidence | In force | High confidence | |
| US 9,441,002 | Dithiolane based thiol modifier for labeling and stronger immobilization of bio-molecules on solid surfaces In force (reinstated) · USPTO record | In force (reinstated) | USPTO record |
Also on record, not counted in the 14: 2 lapsed for an unpaid fee · 9 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 2 no status recorded